Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

250.43 -2.68 (-1.06%)
Streaming Delayed Price Updated: 2:10 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Tesla To $180? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?
Stocks surged as weak economic data raised hopes for Fed rate cut. S&P 500 up 1.2%, Nasdaq 100 up 1.5%, Dow Jones up 0.6%. Spotify shares jump 17% on earnings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Danaher Corp. (NYSE: DHR) Highlighted for Surprising Price Action
Via Investor Brand Network
Spotlight on Danaher: Analyzing the Surge in Options Activity
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Danaher
Via Benzinga
Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives
Pulte received an added data boost, Danaher's markets are looking up, and JetBlue collapses, despite a not-as-bad-as-feared loss. 
Via Investor's Business Daily
DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q1 2024
DHR stock results show that Danaher beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Is Life Science-Focused Danaher Trading Higher On Tuesday?
Danaher Corp's Q1 sales beat expectations despite a Y/Y decrease. Rainer Blair, CEO, highlights strong revenue, earnings, and cash flow. Biotech sales dip, while life sciences and diagnostics segments... 
Via Benzinga
Topics Earnings
Exposures Financial
This Is What Whales Are Betting On Danaher
Via Benzinga
Unpacking the Latest Options Trading Trends in Danaher
Via Benzinga
Danaher Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Looking Into Danaher's Recent Short Interest
Via Benzinga
Earnings Scheduled For April 23, 2024
Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion. 
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Via Benzinga
Billionaire Dan Loeb Just Bought 1 Shocking Stock
Loeb is selling AI stocks for a big dividend payer. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024
Investors wanting to broaden and deepen their portfolio should reach for these healthcare names, each of which is a favorite among analysts. 
Via InvestorPlace
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Danaher's Options Frenzy: What You Need to Know
Via Benzinga
Here's How Much $1000 Invested In Danaher 5 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Invest Like Bill Gates With These 3 AI Stocks to Buy
Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. 
Via Benzinga
Danaher's Spun-Off Company Veralto Is "Next High-Quality Serial Compounder" - Analyst
Analyst initiates coverage on Veralto Corporation at Outperform rating with $97 price target. Sees strong EPS growth, high-margin businesses, and M&A potential. 
Via Benzinga
Unpacking the Latest Options Trading Trends in Danaher
Via Benzinga
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks. 
Via Benzinga
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.